Health
NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…
-
Business15 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
Noosa News13 hours agoGaming policy on council’s agenda
-
Noosa News17 hours agoInside the big change in homebuyer habits during the Christmas holidays
-
Noosa News11 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified